Pubblicazioni

Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension

2020 - CHEST
D'Alto, M.; Badagliacca, R.; Argiento, P.; Romeo, E.; Farro, A.; Papa, S.; Sarubbi, B.; Russo, M. G.; Vizza, C. D.; Golino, P.; Naeije, R.

Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension. clinical and haemodYnamic long-term efficacy (ITALY study)

2018 - JOURNAL OF CARDIOVASCULAR MEDICINE
D'alto, M.; Romeo, E.; Argiento, P.; Paciocco, G.; Prediletto, R.; Ghio, S.; Correale, M.; Lo Giudice, F.; Badagliacca, R.; Greco, A.; Vizza, C. D.

Safety and long-term efficacy of transition from sildenafil to tadalafil due to side effects in patients with pulmonary arterial hypertension

2015 - LUNG
Lichtblau, Mona; Harzheim, Dominik; Ehlken, Nicola; Marra, Alberto; Pinado, Fabiola Pena; Grünig, Ekkehard; Egenlauf, Benjamin

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma